Filgrastim Other names: r-metHuG-CSF

Active ingredient description

Filgrastim causes marked increases in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
L03AA02 Filgrastim L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors
Discover more medicines within L03AA02

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
NEUPOGEN Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
ACCOFIL Solution for injection / infusion European Medicines Agency (EU) MPI, EU: SmPC
NIVESTYM Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

3D molecular structure

3D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 121181-53-1
DrugBank Drug: DB00099
KEGG Drug: D03235
RxNorm Ingredient: 68442
SNOMED-CT Concept: 386948008
Filgrastim (substance)
UNII Identifier: PVI5M0M1GW
FILGRASTIM

Medicines

Filgrastim is an active ingredient of these brands:

United States (US)

Australia (AU)

Israel (IL)

Japan (JP)

New Zealand (NZ)

Singapore (SG)

South Africa (ZA)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.